Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Karyopharm Therapeutics (KPTI) Interest Coverage Ratio (2019 - 2025)

Karyopharm Therapeutics (KPTI) has disclosed Interest Coverage Ratio for 9 consecutive years, with 1.41 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest Coverage Ratio rose 49.35% year-over-year to 1.41, compared with a TTM value of 1.98 through Dec 2025, up 38.02%, and an annual FY2025 reading of 1.98, up 38.02% over the prior year.
  • Interest Coverage Ratio was 1.41 for Q4 2025 at Karyopharm Therapeutics, down from 1.38 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 5.91 in Q4 2021 and bottomed at 10.28 in Q1 2021.
  • Average Interest Coverage Ratio over 5 years is 4.31, with a median of 5.13 recorded in 2023.
  • The sharpest move saw Interest Coverage Ratio skyrocketed 212.85% in 2021, then crashed 197.3% in 2022.
  • Year by year, Interest Coverage Ratio stood at 5.91 in 2021, then crashed by 197.3% to 5.76 in 2022, then decreased by 5.82% to 6.09 in 2023, then surged by 54.16% to 2.79 in 2024, then skyrocketed by 49.35% to 1.41 in 2025.
  • Business Quant data shows Interest Coverage Ratio for KPTI at 1.41 in Q4 2025, 1.38 in Q3 2025, and 2.17 in Q2 2025.